{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:26:15Z","timestamp":1792664775807,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.0826","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T16:31:41Z","timestamp":1532104301000},"page":"e180826","source":"Crossref","is-referenced-by-count":83,"title":["Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures"],"prefix":"10.1001","volume":"1","author":[{"given":"Rishi J.","family":"Desai","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufaddal","family":"Mahesri","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younathan","family":"Abdia","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Barberio","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tong","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Merck & Co, Upper Gwynedd, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Mavros","sequence":"additional","affiliation":[{"name":"Merck & Co, Upper Gwynedd, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung C.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Franklin","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"issue":"20","key":"zoi180062r1","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1001\/archinte.168.20.2261","article-title":"10-Year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.","volume":"168","author":"Hodsman","year":"2008","journal-title":"Arch Intern Med"},{"issue":"10","key":"zoi180062r2","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis.","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"9","key":"zoi180062r3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in US patients between 2002 and 2011.","volume":"29","author":"Solomon","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"5","key":"zoi180062r4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","article-title":"Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.","volume":"128","author":"Kim","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"zoi180062r5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward.","volume":"32","author":"Khosla","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"zoi180062r6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00198-017-4345-0","article-title":"Hip fracture trends in the United States, 2002 to 2015.","volume":"29","author":"Michael Lewiecki","year":"2018","journal-title":"Osteoporos Int"},{"issue":"18","key":"zoi180062r7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture.","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi180062r8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00198-010-1411-2","article-title":"Oral bisphosphonates are associated with reduced mortality after hip fracture.","volume":"22","author":"Beaupre","year":"2011","journal-title":"Osteoporos Int"},{"issue":"3","key":"zoi180062r9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00223-016-0141-7","article-title":"Real-life and RCT participants: alendronate users versus FITs\u2019 trial eligibility criterion.","volume":"99","author":"Reyes","year":"2016","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"zoi180062r10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pds.1908","article-title":"Instrumental variable methods in comparative safety and effectiveness research.","volume":"19","author":"Brookhart","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"434","key":"zoi180062r11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/01621459.1996.10476902","article-title":"Identification of causal effects using instrumental variables.","volume":"91","author":"Angrist","year":"1996","journal-title":"J Am Stat Assoc"},{"issue":"7","key":"zoi180062r12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/pds.1757","article-title":"Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study.","volume":"18","author":"Ionescu-Ittu","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"zoi180062r13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"7","key":"zoi180062r14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0895-4356(92)90047-Q","article-title":"Identification of fractures from computerized Medicare files.","volume":"45","author":"Ray","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi180062r15","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1210\/jc.2011-2645","article-title":"Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).","volume":"97","author":"Majumdar","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"zoi180062r16","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/jgs.12507","article-title":"Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010.","volume":"61","author":"Liu","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"zoi180062r17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jclinepi.2008.12.006","article-title":"Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.","volume":"62","author":"Rassen","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"zoi180062r18","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1002\/art.22219","article-title":"Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.","volume":"54","author":"Schneeweiss","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"zoi180062r19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"3","key":"zoi180062r20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/biomet\/78.3.691","article-title":"A note on a general definition of the coefficient of determination.","volume":"78","author":"Nagelkerke","year":"1991","journal-title":"Biometrika"},{"issue":"4","key":"zoi180062r21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/EDE.0000000000000287","article-title":"Toward a clearer portrayal of confounding bias in instrumental variable applications.","volume":"26","author":"Jackson","year":"2015","journal-title":"Epidemiology"},{"issue":"3","key":"zoi180062r22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/EDE.0000000000000262","article-title":"Instrumental variable estimation in a survival context.","volume":"26","author":"Tchetgen Tchetgen","year":"2015","journal-title":"Epidemiology"},{"issue":"1","key":"zoi180062r23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/biom.12244","article-title":"Instrumental variable additive hazards models.","volume":"71","author":"Li","year":"2015","journal-title":"Biometrics"},{"issue":"12","key":"zoi180062r25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jclinepi.2008.12.005","article-title":"Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships.","volume":"62","author":"Rassen","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"zoi180062r26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.3263","article-title":"One-to-many propensity score matching in cohort studies.","volume":"21","author":"Rassen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"zoi180062r27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects.","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"6","key":"zoi180062r28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-008-0767-z","article-title":"Effect of alendronate in elderly patients after low trauma hip fracture repair.","volume":"20","author":"Cecilia","year":"2009","journal-title":"Osteoporos Int"},{"issue":"2","key":"zoi180062r29","first-page":"499","article-title":"Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis.","volume":"32","author":"Peng","year":"2016","journal-title":"Pak J Med Sci"},{"issue":"4","key":"zoi180062r30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ije\/29.4.722","article-title":"An introduction to instrumental variables for epidemiologists.","volume":"29","author":"Greenland","year":"2000","journal-title":"Int J Epidemiol"},{"issue":"3","key":"zoi180062r31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ede.0000193606.58671.c5","article-title":"Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.","volume":"17","author":"Brookhart","year":"2006","journal-title":"Epidemiology"},{"issue":"4","key":"zoi180062r32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.ede.0000222409.00878.37","article-title":"Instruments for causal inference: an epidemiologist\u2019s dream?","volume":"17","author":"Hern\u00e1n","year":"2006","journal-title":"Epidemiology"},{"issue":"9","key":"zoi180062r33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/jgs.14237","article-title":"One-year mortality after hip fracture: development and validation of a prognostic index.","volume":"64","author":"Cenzer","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"zoi180062r24","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-68560-1","volume-title":"Survival and Event History Analysis: A Process Point of View","author":"Aalen","year":"2008"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/3\/e180826\/17326203\/desai_2018_oi_180062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T20:18:26Z","timestamp":1551212306000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.0826"}},"subtitle":["An Instrumental Variable Analysis"],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7,6]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0826","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]}}}